Vaccine Safety Bibliography - May 2010
1. Interim Results: State-Specific Influenza A (H1N1) 2009 Monovalent Vaccination Coverage - United States, October 2009-January 2010. MMWR Morb Mortal Wkly Rep; 59 (12): 363-368; April 2, 2010.
2. Interim Results: State-Specific Seasonal Influenza Vaccination Coverage - United States, August 2009-January 2010. MMWR Morb Mortal Wkly Rep; 59 (16): 477-484; April 30, 2010.
3. Interim Results: Influenza A (H1N1) 2009 Monovalent and Seasonal Influenza Vaccination Coverage Among Health-Care Personnel - United States, August 2009-January 2010. MMWR Morb Mortal Wkly Rep; 59 (12): 357-362; April 2, 2010.
4. Adam, H. J.; Richardson, S. E.; Jamieson, F. B.; Rawte, P.; Low, D. E.; Fisman, D. N. Changing Epidemiology of Invasive Haemophilus Influenzae in Ontario, Canada: Evidence for Herd Effects and Strain Replacement Due to Hib Vaccination. Vaccine; April 14, 2010.
5. Atchison, C.; Lopman, B.; Edmunds, W. J. Modelling the Seasonality of Rotavirus Disease and the Impact of Vaccination in England and Wales. Vaccine; 28 (18): 3118-3126; April, 2010.
6. Batzing-Feigenbaum, J.; Pruckner, U.; Beyer, A.; Sinn, G.; Dinter, A.; Mankertz, A.; Siedler, A.; Schubert, A.; Suckau, M. Spotlight on Measles 2010: Preliminary Report of an Ongoing Measles Outbreak in a Subpopulation With Low Vaccination Coverage in Berlin, Germany, January-March 2010. Euro Surveill; 15 (13): 19527; April 1, 2010.
7. Betsch, C.; Renkewitz, F.; Betsch, T.; Ulshofer, C. The Influence of Vaccine-Critical Websites on Perceiving Vaccination Risks. J Health Psychol; 15 (3): 446-455; April, 2010.
8. Blencowe, H.; Lawn, J.; Vandelaer, J.; Roper, M.; Cousens, S. Tetanus Toxoid Immunization to Reduce Mortality From Neonatal Tetanus. Int J Epidemiol; 39 (Suppl 1): i102-i109; April, 2010.
9. Blitshteyn, S. Postural Tachycardia Syndrome After Vaccination With Gardasil. Eur J Neurol; April 9, 2010. [Epub ahead of print].
10. Boom, J. A.; Sahni, L. C.; Nelson, C. S.; Dragsbaek, A. C.; Franzini, L. Immunization Information System Opt-In Consent: At What Cost? J Public Health Manag Pract; April 23, 2010. [Epub ahead of print].
11. Bounthavong, M.; Christopher, M. L.; Mendes, M. A.; Foster, E. B.; Johns, S. T.; Lim, L.; Rubin, L. M.; Patel, J. J.; Stewart, A. G. Measuring Patient Satisfaction in the Pharmacy Specialty Immunization Clinic: a Pharmacist-Run Immunization Clinic at the Veterans Affairs San Diego Healthcare System. Int J Pharm Pract; 18 (2): 100-107; April, 2010.
12. Brisson, M.; Melkonyan, G.; Drolet, M.; De, Serres G.; Thibeault, R.; De, Wals P. Modeling the Impact of One- and Two-Dose Varicella Vaccination on the Epidemiology of Varicella and Zoster. Vaccine; 28 (19): 3385-3397; April 26, 2010.
13. Brockhoff, H. J.; Mollema, L.; Sonder, G. J.; Postema, C. A.; van Binnendijk, R. S.; Kohl, R. H.; de Melker, H. E.; Hahne, S. J. Mumps Outbreak in a Highly Vaccinated Student Population, The Netherlands, 2004. Vaccine; 28 (17): 2932-2936; April 9, 2010.
14. Brown, K. F.; Kroll, J. S.; Hudson, M. J.; Ramsay, M.; Green, J.; Long, S. J.; Vincent, C. A.; Fraser, G.; Sevdalis, N. Factors Underlying Parental Decisions About Combination Childhood Vaccinations Including MMR: A Systematic Review. Vaccine; April 30, 2010. [Epub ahead of print].
15. Caban-Martinez, A. J.; Lee, D. J.; Davila, E. P.; LeBlanc, W. G.; Arheart, K. L.; McCollister, K. E.; Christ, S. L.; Clarke, T.; Fleming, L. E. Sustained Low Influenza Vaccination Rates in US Healthcare Workers. Prev Med; 50 (4): 210-212; April, 2010.
16. Cawley, J.; Hull, H. F.; Rousculp, M. D. Strategies for Implementing School-Located Influenza Vaccination of Children: a Systematic Literature Review. J Sch Health; 80 (4): 167-175; April, 2010.
17. Centenari, C.; Gurgel, R. Q.; Bohland, A. K.; Oliveira, D. M.; Faragher, B.; Cuevas, L. E. Rotavirus Vaccination in Northeast Brazil: A Laudable Intervention, but Can It Lead to Cost-Savings? Vaccine; April 23, 2010. [Epub ahead of print].
18. Chandir, S.; Khan, A. J.; Hussain, H.; Usman, H. R.; Khowaja, S.; Halsey, N. A.; Omer, S. B. Effect of Food Coupon Incentives on Timely Completion of DTP Immunization Series in Children From a Low-Income Area in Karachi, Pakistan: a Longitudinal Intervention Study. Vaccine; 28 (19): 3473-3478; April 26, 2010.
19. Chibuk, T. K.; Robinson, J. L.; Hartfield, D. S. Pediatric Complicated Pneumonia and Pneumococcal Serotype Replacement: Trends in Hospitalized Children Pre and Post Introduction of Routine Vaccination With Pneumococcal Conjugate Vaccine (PCV7). Eur J Pediatr; April 10, 2010. [Epub ahead of print].
20. Chlibek, R.; Anca, I.; Andre, F.; Bakir, M.; Ivaskeviciene, I.; Mangarov, A.; Meszner, Z.; Perenovska, P.; Prymula, R.; Richter, D.; Salman, N.; Simurka, P.; Tamm, E.; Toplak, N.; Usonis, V. Central European Vaccination Advisory Group (CEVAG) Guidance Statement on Recommendations for 2009 Pandemic Influenza A(H1N1) Vaccination. Vaccine; April 7, 2010. [Epub ahead of print].
21. Chuaychoo, B.; Wongsurakiat, P.; Nana, A.; Kositanont, U.; Maranetra, K. N. The Immunogenicity of Intradermal Influenza Vaccination in COPD Patients. Vaccine; April, 2010. [Epub ahead of print].
22. Clark-Forsting, M. Community-Based HPV Vaccination for Rural Wisconsin. WMJ; 109 (2): 109; April, 2010.
23. Cohen, J. I.; Hohman, P.; Fulton, R.; Turk, S. P.; Qin, J.; Thatcher, K.; Hornung, R. L. Kinetics of Serum Cytokines After Primary or Repeat Vaccination With the Smallpox Vaccine. J Infect Dis; 201 (8): 1183-1191; April 15, 2010.
24. Danziger-Isakov, L.; Cherkassky, L.; Siegel, H.; McManamon, M.; Kramer, K.; Budev, M.; Sawinski, D.; Augustine, J. J.; Hricik, D. E.; Fairchild, R.; Heeger, P. S.; Poggio, E. D. Effects of Influenza Immunization on Humoral and Cellular Alloreactivity in Humans. Transplantation; 89 (7): 838-844; April 15, 2010.
25. de Carvalho, J. F.; Pereira, R. M.; Shoenfeld, Y. Vaccination for Atherosclerosis. Clin Rev Allergy Immunol; 38 (2-3): 135-140; April, 2010.
26. de Los Reyes, E. C. Autism and Immunizations: Separating Fact From Fiction. Arch Neurol; 67 (4): 490-492; April, 2010.
27. Dominguez, A.; Torner, N.; Castilla, J.; Batalla, J.; Godoy, P.; Guevara, M.; Carnicer, D.; Cayla, J.; Rius, C.; Jansa, J. M. Mumps Vaccine Effectiveness in Highly Immunized Populations. Vaccine; 28 (20): 3567-3570; April 30, 2010.
28. El-Zein, M.; Parent, M. E.; Benedetti, A.; Rousseau, M. C. Does BCG Vaccination Protect Against the Development of Childhood Asthma? A Systematic Review and Meta-Analysis of Epidemiological Studies. Int J Epidemiol; 39 (2): 469-486; April, 2010.
29. Elberse, K. E.; Tcherniaeva, I.; Berbers, G. A.; Schouls, L. M. Optimization and Application of a Multiplex Bead-Based Assay to Quantify Serotype-Specific IgG Against Streptococcus Pneumoniae Polysaccharides: Response to the Booster Vaccine After Immunization With the Pneumococcal 7-Valent Conjugate Vaccine. Clin Vaccine Immunol; 17 (4): 674-682; April, 2010.
30. Ferguson, P. E.; Jordens, C. F.; Gilroy, N. M. Patient and Family Education in HSCT: Improving Awareness of Respiratory Virus Infection and Influenza Vaccination. A Descriptive Study and Brief Intervention. Bone Marrow Transplant; 45 (4): 656-661; April, 2010.
31. Fernandez, M. E.; Allen, J. D.; Mistry, R.; Kahn, J. A. Integrating Clinical, Community, and Policy Perspectives on Human Papillomavirus Vaccination. Annu Rev Public Health; 31: 235-252; April 21, 2010.
32. Gendrel, D.; Vallet, C.; Gelmetti, C.; Moulin, F.; Brasme, J. F.; Chalumeau, M.; Cohen, R.; Raymond, J. [Pneumococcal Pneumonia Highly Probable in Immunized Children Cared for in-Group Settings]. Arch Pediatr; 17 (4): 373-377; April, 2010.
33. Gold, M. S.; Gidudu, J.; Erlewyn-Lajeunesse, M.; Law, B. Can the Brighton Collaboration Case Definitions Be Used to Improve the Quality of Adverse Event Following Immunization (AEFI) Reporting? Anaphylaxis As a Case Study. Vaccine; [Epub ahead of print]. (; April 28, 2010.
34. Grose, C. Stroke After Varicella and Zoster Ophthalmicus: Another Indication for Treatment and Immunization. Pediatr Infect Dis J; April 15, 2010. [Epub ahead of print].
35. Guthmann, J. P.; Fonteneau, L.; Antona, D.; Levy-Bruhl, D. [Factors Associated With Tetanus Vaccination Coverage in Adults in France and With Knowledge of Vaccination Status.]. Med Mal Infect; April 16, 2010. [Epub ahead of print].
36. Halliley, J. L.; Kyu, S.; Kobie, J. J.; Walsh, E. E.; Falsey, A. R.; Randall, T. D.; Treanor, J.; Feng, C.; Sanz, I.; Lee, F. E. Peak Frequencies of Circulating Human Influenza-Specific Antibody Secreting Cells Correlate With Serum Antibody Response After Immunization. Vaccine; 28 (20): 3582-3587; April 30, 2010.
37. Halm, A.; Yalcouye, I.; Kamissoko, M.; Keita, T.; Modjirom, N.; Zipursky, S.; Kartoglu, U.; Ronveaux, O. Using Oral Polio Vaccine Beyond the Cold Chain: a Feasibility Study Conducted During the National Immunization Campaign in Mali. Vaccine; 28 (19): 3467-3472; April 26, 2010.
38. High, K. P.; D'Aquila, R. T.; Fuldner, R. A.; Gerding, D. N.; Halter, J. B.; Haynes, L.; Hazzard, W. R.; Jackson, L. A.; Janoff, E.; Levin, M. J.; Nayfield, S. G.; Nichol, K. L.; Prabhudas, M.; Talbot, H. K.; Clayton, C. P.; Henderson, R.; Scott, C. M.; Tarver, E. D.; Woolard, N. F.; Schmader, K. E. Workshop on Immunizations in Older Adults: Identifying Future Research Agendas. J Am Geriatr Soc; 58 (4): 765-776; April, 2010.
39. Hinman, A. R.; Ross, D. A. Immunization Registries Can Be Building Blocks for National Health Information Systems. Health Aff (Millwood); 29 (4): 676-682; April, 2010.
40. Homme, J. H.; Fischer, P. R. Randomised Controlled Trial: Prophylactic Paracetamol at the Time of Infant Vaccination Reduces the Risk of Fever but Also Reduces Antibody Response. Evid Based Med; 15 (2): 50-51; April, 2010.
41. Houweling, H.; Verweij, M.; Ruitenberg, E. J. Criteria for Inclusion of Vaccinations in Public Programmes. Vaccine; 28 (17): 2924-2931; April 9, 2010.
42. Hsieh, Y. H. Age Groups and Spread of Influenza: Implications for Vaccination Strategy. BMC Infect Dis; 10 (1): 106; April 30, 2010.
43. Huang, W. T.; Chuang, J. H.; Kuo, S. H. Monitoring the Safety of Pandemic H1N1 Vaccine. Lancet; 375 (9721): 1164; April 3, 2010.
44. Huang, Y.; Park, Y. S.; Moon, C.; David, A. E.; Chung, H. S.; Yang, V. C. Synthetic Skin-Permeable Proteins Enabling Needleless Immunization. Angew Chem Int Ed Engl; 49 (15): 2724-2727; April, 2010.
45. Iorio, A.; Basileo, M.; Marcucci, M.; Guercini, F.; Camilloni, B.; Paccamiccio, E.; Vecchioli, M.; Iorio, A. M. Influenza Vaccination and Vitamin K Antagonist Treatment: a Placebo-Controlled, Randomized, Double-Blind Crossover Study. Arch Intern Med; 170 (7): 609-616; April 12, 2010.
46. Jagu, S.; Kwak, K.; Garcea, R. L.; Roden, R. B. Vaccination With Multimeric L2 Fusion Protein and L1 VLP or Capsomeres to Broaden Protection Against HPV Infection. Vaccine; April 28, 2010. [Epub ahead of print].
47. Jenlink, C. H.; Kuehnert, P.; Mazyck, D. H1N1 Vaccinations, Fall 2009: Model School-Located Vaccination Clinics. J Sch Nurs; April 23, 2010. [Epub ahead of print].
48. Jeong, Y. W.; Park, B. H.; Kim, K. H.; Han, Y. R.; Go, U. Y.; Choi, W. S.; Kong, K. A.; Park, H. Timeliness of MMR Vaccination and Barriers to Vaccination in Preschool Children. Epidemiol Infect; 1-10; April 23, 2010.
49. Kaufmann, S. H. Novel Tuberculosis Vaccination Strategies Based on Understanding the Immune Response. J Intern Med; 267 (4): 337-353; April, 2010.
50. Keeton, V. F.; Chen, A. K. Immunization Updates and Challenges. Curr Opin Pediatr; 22 (2): 234-240; April, 2010.
51. Kieninger, D. M.; Kueper, K.; Steul, K.; Juergens, C.; Ahlers, N.; Baker, S.; Jansen, K. U.; Devlin, C.; Gruber, W. C.; Emini, E. A.; Scott, D. A. Safety, Tolerability, and Immunologic Noninferiority of a 13-Valent Pneumococcal Conjugate Vaccine Compared to a 7-Valent Pneumococcal Conjugate Vaccine Given With Routine Pediatric Vaccinations in Germany. Vaccine; April 22, 2010. [Epub ahead of print].
52. Kristjansdottir, O.; Kristjansdottir, G. Randomized Clinical Trial of Musical Distraction With and Without Headphones for Adolescents' Immunization Pain. Scand J Caring Sci; April 14, 2010. [Epub ahead of print].
53. Kuehnert, P. Now More Than Ever: Building and Sustaining Capacity for School-Located Vaccination Initiatives. J Sch Nurs; April 21, 2010. [Epub ahead of print].
54. Labrie, J. E., III; Keiser, P. B. Whole Cell Vaccination for Meningococcus: Lessons From an Idea Whose Time Has Gone. Hum Vaccin; 6 (4); April 27, 2010.
55. Lachenal, F.; Sebban, C.; Duruisseaux, M.; Biron, P.; Blay, J. Y.; Ghesquieres, H. Influenza Vaccination in Patients With Haematologic Malignancies: Analysis of Practices in 200 Patients in a Single Center. Bull Cancer; 97 (4): E33-E36; April, 2010.
56. Leask, J.; Chapman, S.; Cooper Robbins, S. C. "All Manner of Ills": The Features of Serious Diseases Attributed to Vaccination. Vaccine; 28 (17): 3066-3070; April 9, 2010.
57. Lee, K.; Harmer, A. Ten Years of the Global Alliance for Vaccines and Immunisation. BMJ; 340: c2004; April, 2010.
58. Leung, J. S. Adverse Events After Flu Vaccination in Patients With Immune Disorders. Hong Kong Med J; 16 (2): 159; April, 2010.
59. Li, G.; Zhang, H.; Zhou, W.; Ye, Q.; Li, F.; Wang, H.; Hou, Q.; Xu, Y.; Ma, X.; Tan, Y.; Wang, L.; Li, Y.; Li, H.; Meng, F.; Liang, Q.; Liu, A.; Qin, C.; Wei, W.; Liu, J.; Ruan, C.; Tao, W.; Zhang, S.; Zheng, H.; Zhu, F. Safety and Immunogenicity of a Diphtheria, Tetanus, Acellular Pertussis and Haemophilus Influenzae Type b Combination Vaccine Compared With Separate Administration of Licensed Equivalent Vaccines in Chinese Infants and Toddlers for Primary and Booster Immunization. Vaccine; April 15, 2010. [Epub ahead of print].
60. Li, Y.; Mukamel, D. B. Racial Disparities in Receipt of Influenza and Pneumococcus Vaccinations Among US Nursing-Home Residents. Am J Public Health; 100 (Suppl 1): S256-S262; April 1, 2010.
61. Li, Z.; Doan, Q.; Dobson, S. Determinants of Influenza Immunization Uptake in Canadian Youths. Vaccine; 28 (19): 3462-3466; April 26, 2010.
62. Lin, N. D.; Kleinman, K.; Chan, K. A.; Soumerai, S.; Mehta, J.; Mullooly, J. P.; Shay, D. K.; Kolczak, M.; Lieu, T. A. Multiple Vaccinations and the Risk of Medically Attended Fever. Vaccine; April 18, 2010. [Epub ahead of print].
63. Lisotti, A.; Roda, G.; Brillanti, S.; Roda, E. Reactivation of Crohn's Disease After Pandemic AH1N1 and Seasonal Flu Vaccinations. Dig Liver Dis; April 22, 2010. [Epub ahead of print].
64. Llupia, A.; Garcia-Basteiro, A. L.; Olive, V.; Costas, L.; Rios, J.; Quesada, S.; Varela, P.; Bayas, J. M.; Trilla, A. New Interventions to Increase Influenza Vaccination Rates in Health Care Workers. Am J Infect Control; April 24, 2010. [Epub ahead of print].
65. Loeb, M.; Earn, D. J.; Smieja, M.; Webby, R. Pandemic (H1N1) 2009 Risk for Nurses After Trivalent Vaccination. Emerg Infect Dis; 16 (4): 719-720; April, 2010.
66. Lopalco, P. L.; Martin, R. Measles Still Spreads in Europe: Who Is Responsible for the Failure to Vaccinate? Euro Surveill; 15 (17): 19557; April 29, 2010.
67. Makidon, P. E.; Nigavekar, S. S.; Bielinska, A. U.; Mank, N.; Shetty, A. M.; Suman, J.; Knowlton, J.; Myc, A.; Rook, T.; Baker, J. R., Jr. Characterization of Stability and Nasal Delivery Systems for Immunization With Nanoemulsion-Based Vaccines. J Aerosol Med Pulm Drug Deliv; 23 (2): 77-89; April, 2010.
68. Mantadakis, E.; Farmaki, E.; Buchanan, G. R. Thrombocytopenic Purpura After Measles-Mumps-Rubella Vaccination: a Systematic Review of the Literature and Guidance for Management. J Pediatr; 156 (4): 623-628; April, 2010.
69. Marchiondo, K. J. Recognizing and Treating Vasovagal Syncope. Am J Nurs; 110 (4): 50-53; April, 2010.
70. Marcotte, G. V. Clinical Pearls for H1N1 Influenza Vaccination. J Allergy Clin Immunol; 125 (4): 951-952; April, 2010.
71. Mazyck, D. School-Located Vaccination Clinics: Then and Now. J Sch Nurs; April 21, 2010. [Epub ahead of print].
72. McRee, A. L.; Reiter, P. L.; Brewer, N. T. Vaccinating Adolescent Girls Against Human Papillomavirus-Who Decides? Prev Med; 50 (4): 213-214; April, 2010.
73. Miravalle, A.; Biller, J.; Schnitzler, E.; Bonwit, A. Neurological Complications Following Vaccinations. Neurol Res; 32 (3): 285-292; April, 2010.
74. Molloy, G. J. Increasing Influenza Vaccination Rates: Where Is the Behaviour Change Theory? Vaccine; 28 (21): 3632; May 7, 2010.
75. Monteiro, S. A.; Takano, O. A.; Waldman, E. A. Surveillance for Adverse Events After DTwP/Hib Vaccination in Brazil: Sensitivity and Factors Associated With Reporting. Vaccine; 28 (18): 3127-3133; April, 2010.
76. Niewoehner, D. E. Clinical Practice. Outpatient Management of Severe COPD. N Engl J Med; 362 (15): 1407-1416; April 15, 2010.
77. O'Grady, K. A.; Lee, K. J.; Carlin, J. B.; Torzillo, P. J.; Chang, A. B.; Mulholland, E. K.; Lambert, S. B.; Andrews, R. M. Increased Risk of Hospitalization for Acute Lower Respiratory Tract Infection Among Australian Indigenous Infants 5-23 Months of Age Following Pneumococcal Vaccination: a Cohort Study. Clin Infect Dis; 50 (7): 970-978; April 1, 2010.
78. Paulke-Korinek, M.; Rendi-Wagner, P.; Kundi, M.; Kronik, R.; Kollaritsch, H. Universal Mass Vaccination Against Rotavirus Gastroenteritis: Impact on Hospitalization Rates in Austrian Children. Pediatr Infect Dis J; 29 (4): 319-323; April, 2010.
79. Pereira, A.; Pietro Pereira, A. S.; Silva, C. L.; de Melo, Rocha G.; Lebrun, I.; Sant'Anna, O. A.; Tambourgi, D. V. Antibody Response From Whole-Cell Pertussis Vaccine Immunized Brazilian Children Against Different Strains of Bordetella Pertussis. Am J Trop Med Hyg; 82 (4): 678-682; April, 2010.
80. Plans, P. Prevalence of Antibodies Associated With Herd Immunity: A New Indicator to Evaluate the Establishment of Herd Immunity and to Decide Immunization Strategies. Med Decis Making; April 16, 2010. [Epub ahead of print].
81. Poland, G. A.; Morse, D. Improving the Public Health: the U.S. Recommendation for Universal Influenza Immunization. Vaccine; 28 (16): 2799-2800; April 1, 2010.
82. Reygrobellet, C.; Viala-Danten, M.; Meunier, J.; Weber, F.; Nguyen, V. H. Perception and Acceptance of Intradermal Influenza Vaccination: Patient Reported Outcomes From Phase 3 Clinical Trials. Hum Vaccin; 6 (4); April 26, 2010.
83. Rezaei, N.; Siadat, S. D.; Aghamohammadi, A.; Moin, M.; Pourpak, Z.; Norouzian, D.; Mobarakeh, J. I.; Aghasadeghi, M. R.; Nejati, M.; Read, R. C. Serum Bactericidal Antibody Response 1 Year After Meningococcal Polysaccharide Vaccination of Patients With Common Variable Immunodeficiency. Clin Vaccine Immunol; 17 (4): 524-528; April, 2010.
84. Rosenthal, S. L.; Zimet, G. D. Adolescent Males and Human Papillomavirus: Psychosexual Development, Infection, and Vaccination. J Adolesc Health; 46 (4 Suppl): S1-S2; April, 2010.
85. Sander, B.; Kwong, J. C.; Bauch, C. T.; Maetzel, A.; McGeer, A.; Raboud, J. M.; Krahn, M. Economic Appraisal of Ontario's Universal Influenza Immunization Program: a Cost-Utility Analysis. PLoS Med; 7 (4): e1000256; April 6, 2010.
86. Sauerwein, R. W.; Bijker, E. M.; Richie, T. L. Empowering Malaria Vaccination by Drug Administration. Curr Opin Immunol; April 29, 2010. [Epub ahead of print].
87. Schumacher, Z.; Bourquin, C.; Heininger, U. Surveillance for Adverse Events Following Immunization (AEFI) in Switzerland-1991-2001. Vaccine; April 18, 2010. [Epub ahead of print].
88. Schwarzinger, M.; Flicoteaux, R.; Cortarenoda, S.; Obadia, Y.; Moatti, J. P. Low Acceptability of A/H1N1 Pandemic Vaccination in French Adult Population: Did Public Health Policy Fuel Public Dissonance? PLoS One; 5 (4): e10199; April 16, 2010.
89. Seale, H.; Wang, Q.; Yang, P.; Dwyer, D. E.; Wang, X.; Zhang, Y.; Macintyre, C. R. Influenza Vaccination Amongst Hospital Health Care Workers in Beijing. Occup Med (Lond); April 23, 2010. [Epub ahead of print].
90. Siedler, A.; Arndt, U. Impact of the Routine Varicella Vaccination Programme on Varicella Epidemiology in Germany. Euro Surveill; 15 (13): 19530; April 1, 2010.
91. Stefanoff, P.; Orlikova, H.; Rogalska, J.; Kazanowska-Zielinska, E.; Slodzinski, J. Mass Immunisation Campaign in a Roma Settled Community Created an Opportunity to Estimate Its Size and Measles Vaccination Uptake, Poland, 2009. Euro Surveill; 15 (17): 19552; April 29, 2010.
92. Steinhoff, M. C.; Omer, S. B.; Roy, E.; Arifeen, S. E.; Raqib, R.; Altaye, M.; Breiman, R. F.; KZ, M. B. B. S. Influenza Immunization in Pregnancy--Antibody Responses in Mothers and Infants. N Engl J Med; 362 (17): 1644-1646; April 29, 2010.
93. Sudfeld, C. R.; Navar, A. M.; Halsey, N. A. Effectiveness of Measles Vaccination and Vitamin A Treatment. Int J Epidemiol; 39 (Suppl 1): i48-i55; April, 2010.
94. Sugerman, D. E.; Barskey, A. E.; Delea, M. G.; Ortega-Sanchez, I. R.; Bi, D.; Ralston, K. J.; Rota, P. A.; Waters-Montijo, K.; Lebaron, C. W. Measles Outbreak in a Highly Vaccinated Population, San Diego, 2008: Role of the Intentionally Undervaccinated. Pediatrics; 125 (4): 747-755; April, 2010.
95. Tan, T. Q.; Gerbie, M. V. Pertussis and Patient Safety: Implementing Tdap Vaccine Recommendations in Hospitals. Jt Comm J Qual Patient Saf; 36 (4): 173-178; April, 2010.
96. Tandon, M. K.; Phillips, M.; Waterer, G.; Dunkley, M.; Comans, P.; Clancy, R. Oral Immunotherapy With Inactivated Nontypeable Haemophilus Influenzae Reduces Severity of Acute Exacerbations in Severe COPD. Chest; 137 (4): 805-811; April, 2010.
97. Techasaensiri, C.; Messina, A. F.; Katz, K.; Ahmad, N.; Huang, R.; McCracken, G. H., Jr. Epidemiology and Evolution of Invasive Pneumococcal Disease Caused by Multidrug Resistant Serotypes of 19A in the 8 Years After Implementation of Pneumococcal Conjugate Vaccine Immunization in Dallas, Texas. Pediatr Infect Dis J; 29 (4): 294-300; April, 2010.
98. Terry, A. J. Pulse Vaccination Strategies in a Metapopulation SIR Model. Math Biosci Eng; 7 (2): 455-477; April, 2010.
99. Tokizawa, A.; Nagai, K.; Hirakawa, S.; Sonoda, T.; Chosa, T.; Sopaseuth, S.; Akkhavong, S.; Mori, M.; Tsutusmi, H. Importance of Information Sharing to Improve Immunization Coverage for the Expanded Programme on Immunization in Lao People's Democratic Republic. J Trop Pediatr; 56 (2): 131-132; April, 2010.
100. Traynor, K. Everyone Needs Seasonal Flu Vaccination, CDC Advisers Say. Am J Health Syst Pharm; 67 (7): 509-510; April 1, 2010.
101. van den Biggelaar, A. H.; Holt, P. G. 99th Dahlem Conference on Infection, Inflammation and Chronic Inflammatory Disorders: Neonatal Immune Function and Vaccine Responses in Children Born in Low-Income Versus High-Income Countries. Clin Exp Immunol; 160 (1): 42-47; April, 2010.
102. van Assen, S.; Holvast, A.; Telgt, D. S.; Benne, C. A.; de, Haan A.; Westra, J.; Kallenberg, C. G.; Bijl, M. Patients With Humoral Primary Immunodeficiency Do Not Develop Protective Anti-Influenza Antibody Titers After Vaccination With Trivalent Subunit Influenza Vaccine. Clin Immunol; April 24, 2010. [Epub ahead of print].
103. van Boven, M.; Kretzschmar, M.; Wallinga, J.; O'Neill, P. D.; Wichmann, O.; Hahne, S. Estimation of Measles Vaccine Efficacy and Critical Vaccination Coverage in a Highly Vaccinated Population. J R Soc Interface; April 14, 2010. [Epub ahead of print].
104. Viboud, C.; Simonsen, L. Does Seasonal Influenza Vaccination Increase the Risk of Illness With the 2009 A/H1N1 Pandemic Virus? PLoS Med; 7 (4): e1000259; April 6, 2010.
105. von Linstow, M. L.; Pontoppidan, P. L.; von Konig, C. H.; Cherry, J. D.; Hogh, B. Evidence of Bordetella Pertussis Infection in Vaccinated 1-Year-Old Danish Children. Eur J Pediatr; April 8, 2010. [Epub ahead of print].
106. Whelan, J.; van, Binnendijk R.; Greenland, K.; Fanoy, E.; Khargi, M.; Yap, K.; Boot, H.; Veltman, N.; Swaan, C.; van der, Bij A.; de, Melker H.; Hahne, S. Ongoing Mumps Outbreak in a Student Population With High Vaccination Coverage, Netherlands, 2010. Euro Surveill; 15 (17): 19554; April 29, 2010.
[top]
